Retraction
Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma
Paper Information
Record ID:
54887
Author(s):
Journal:
Publication Date:
August 21, 2022
Retraction Date:
July 19, 2023
(2.3 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9756735Additional Notes:
See also: https://pubpeer.com/publications/BB4B71D8A0B30D8694025E0846C423
Citations (12)
12
Total Citations5
Post-Retraction(41.7%)
5
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
410
Days since retraction (latest)
Paper citing Research Progress of PI3K/PTEN/AKT Signaling Pathw...
Unknown Authors
Unknown Journal
Published: Unknown
LINC01094: A Key Long Non-Coding RNA in the Regulation of Cancer Progression and Therapeutic Targets
Qiang Yi, Gangfeng Zhu, Weijian Zhu et al. (8 authors)
Heliyon
Open Access
Published: Sep 2024
410 days after retraction
Melatonin effect on breast and ovarian cancers by targeting the <scp>PI3K</scp>/<scp>Akt</scp>/<scp>mTOR</scp> pathway
Vahid Pourbarkhordar, Sohrab Rahmani, Ali Roohbakhsh et al. (5 authors)
IUBMB Life
Published: Aug 2024
7 citations
7 citations
408 days after retraction
A model and multi-core parallel co-evolution algorithm for identifying cancer driver pathways
Xiaorong Chen, Jingli Wu, Zheng Deng et al. (4 authors)
Engineering Applications of Artificial Intelligence
Published: May 2024
317 days after retraction
Diverse roles of UBE2S in cancer and therapy resistance: Biological functions and mechanisms
Mengjun Zhang, Jialin Wang, Zidi Zhang et al. (6 authors)
Heliyon
Open Access
Published: Jan 2024
2 citations
2 citations
166 days after retraction
New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis
Mehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi et al. (16 authors)
Pathology - Research and Practice
Published: Oct 2023
13 citations
13 citations
94 days after retraction
Retracted: Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma
Disease Markers
Disease Markers
Open Access
Published: Jul 2023
Same day as retraction
Exosomal miRNAs assist in the crosstalk between tumor cells and immune cells and its potential therapeutics
Xinyue Chen, Yuqiu Li, Miao Li et al. (8 authors)
Life Sciences
Published: Jul 2023
4 citations
4 citations
4 days before retraction
Recent progress in targeted therapy for non-small cell lung cancer
Yanxia Xiao, Pu Liu, Jie Wei et al. (6 authors)
Frontiers in Pharmacology
Open Access
Published: Feb 2023
51 citations
51 citations
148 days before retraction
Mitochondrial phosphoenolpyruvate carboxykinase inhibits kidney renal clear cell carcinoma malignant progression, leading to cell energy metabolism imbalance.
Yeda Chen, Zhu Wang, Qiong Deng et al. (5 authors)
PubMed
Published: Jan 2023
3 citations
3 citations
199 days before retraction
New Research Progress of P-Glycoprotein in Tumor
青 邹
World Journal of Cancer Research
Published: Jan 2023
199 days before retraction
Silencing of YTHDF1 Attenuates Cerebral Stroke by Inducing PTEN Degradation and Activating the PTEN/AKT/mTOR Pathway
Xiaohong Li, Peng An, Fang Han et al. (6 authors)
Molecular Biotechnology
Published: Oct 2022
15 citations
15 citations
273 days before retraction
Quick Stats
Total Citations:
12
Years Since Retraction:
2.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025